BioLargo, Inc.
BLGO
$0.16
$0.00-1.82%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 54.43% | -443.62% | -3.20% | -13.91% | -88.83% |
| Total Depreciation and Amortization | 33.01% | 27.16% | -4.71% | 26.87% | -1.47% |
| Total Amortization of Deferred Charges | 130.77% | 0.00% | 39.29% | -- | -- |
| Total Other Non-Cash Items | -98.77% | 24,550.00% | 75.38% | -129.95% | 208.50% |
| Change in Net Operating Assets | 426.73% | 67.67% | -42.46% | 39.04% | -24.71% |
| Cash from Operations | 42.37% | -30.26% | -15.74% | 4.49% | -18.27% |
| Capital Expenditure | 60.61% | -- | -- | -- | 164.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 50.52% | -- | -- | -- |
| Cash from Investing | -105.08% | 33.33% | -- | -- | -46.15% |
| Total Debt Issued | -- | -100.00% | 22.20% | -31.71% | -- |
| Total Debt Repaid | 300.00% | -80.00% | -25.00% | -100.00% | 50.00% |
| Issuance of Common Stock | -33.05% | -31.78% | 612.54% | -59.59% | -4.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 200.00% | -- | -- |
| Cash from Financing | -73.33% | 26.01% | 227.14% | -45.60% | 108.38% |
| Foreign Exchange rate Adjustments | -250.00% | -- | 100.00% | -142.55% | 291.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -161.67% | 18.52% | 192.17% | -194.61% | 62.17% |